Online Pharmacy News RSS:

All Health News and Articles

Roche and GlaxoSmithKline Bonviva gets Scottish approval

The Scottish Medicines Consortium (SMC) has given its approval of Bonviva (ibandronic acid) for the use within NHS Scotland for the treatment of osteoporosis. The body stated that the once a month treatment was found "to significantly reduce the risk of vertebral fractures in postmenopausal women". Read more…

MPs back blanket smoking ban

MPs have voted to extend a smoking ban in public places to all pubs and private clubs in England. The free vote in the House of Commons went 384 to 184 in the government's favour last night to remove the exemption of private members' clubs and establishments that serve food. MPs also voted to ban smoking in workplaces, including 106,000 licensed premises. Read more…

Secure Symbology, Inc. Introduces New Technology ?– Protects Consumers from Counterfeit Prescription Drugs

NewswireToday (newswire) - 01/28/2008 Paramus, NJ United States - To address the growing concern of counterfeit prescription drugs, Secure Symbology, an innovative New Jersey-based company, has successfully developed and implemented the only tested and proven anti-counterfeiting solution available Read more…

Safety Concerns Prompt FDA to Negatively Review Genentech-Roche's Avastin?® for Breast Cancer

NewswireToday (newswire) - 01/25/2008 London, United Kingdom - Report Buyer, the online destination for business intelligence for major industry sectors, has added a report which finds that an FDA advisory panel has said that Genentech/Roche's Avastin?® should not receive FDA approval for metastatic breast cancer Read more…

New Report Says the Nicotine Dependence Prescription Drug Market will Hit $4.6 billion by 2016

NewswireToday (newswire) - 01/25/2008 London, United Kingdom - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which predicts that the nicotine dependence prescription drug market to grow to $4.6 billion across the seven major markets by 2016 Read more…

Greater Patient Awareness Vital for Improving Diagnosis Rates of Asthma and Chronic Obstructive Pulmonary Disease

NewswireToday (newswire) - 01/24/2008 Palo Alto, CA United States - New analysis from Frost & Sullivan, U.S. Asthma/COPD Market, finds that the market earned revenues of $11.46 billion in 2006 and estimates this to reach $20.21 billion in 2013 Read more…

AnaSpec Introduces New Line of HABA-Biotin Quantitation Kits

NewswireToday (newswire) - 01/22/2008 San Jose, CA United States - AnaSpec has introduced a new line of HABA Biotin Quantitation Kits. They provide a convenient method for estimating the molar ratio of biotin to protein on biotinylated conjugates and also be used to quantitate the biotin concentration in a solution Read more…

Anavex Outlines Corporate Milestones ?– Drug Advancement Plans For 2008

NewswireToday (newswire) - 01/22/2008 Geneva, Switzerland - Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) reported today that the company achieved significant development of its lead drug candidates and in the growth of its management and scientific teams during 2007 Read more…

AdvantaPure?® Introduces Single Use Process Systems for the Pharmaceutical Industry

NewswireToday (newswire) - 01/22/2008 Southampton, PA United States - Cost-saving Single Use Process Systems of silicone tubing, molded components, and parts such as bags and bottles are now available from AdvantaPure. The systems reduce contamination risks, simplify cleaning procedures, and offer design flexibility Read more…

CorePharma Selects rfXcel for California ePedigree Compliance

NewswireToday (newswire) - 01/22/2008 San Ramon, CA United States - Pharmaceutical Industry's Easiest to Use and Most Production-Proven E-Pedigree Solution to Insure California Compliance for CorePharma Read more…

AnaSpec Announces a Broad Selection of T-Cell Epitopes

NewswireToday (newswire) - 01/21/2008 San Jose, CA United States - AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled Read more…

InnoMed PredTox Presents Analysis Results from Systems Toxicology Studies

NewswireToday (newswire) - 01/21/2008 Basel, Switzerland - At the latest meeting of the consortium in Antwerp on January 14-15, hosted by J&J, InnoMed PredTox reached another milestone. Representatives of the sixteen study sponsors presented the Integrated Study Reports for their respective compound studies Read more…

New Technology Innovations to Propel Cell-based Diagnostic Market to Nearly $9 Billion

NewswireToday (newswire) - 01/18/2008 London, United Kingdom - Report Buyer added a new report showing that cell-based diagnostics generated more than $6 billion in revenues last year Read more…

Genedata Provides Expressionist Platform to Eisai Research Institute

NewswireToday (newswire) - 01/17/2008 Basel, Switzerland - Genedata, a leading provider of in silico solutions for the pharmaceutical and life sciences industries, today announced an agreement with the Eisai Research Institute (ERI) for the company?’s Genedata Expressionist?® biomarker discovery platform Read more…

Anavex Advances Drug Candidate for Treatment of Alzheimer's Disease

NewswireToday (newswire) - 01/16/2008 Geneva, Switzerland - Results from animal model testing demonstrate ANAVEX 1-41 has significant neuroprotective and anti-amnesic benefits ("ANAVEX") (OTCBB: AVXL) Read more…

Anavex Advances Drug Candidates for Treatment of Epilepsy

NewswireToday (newswire) - 01/15/2008 Geneva, Switzerland - Results in epilepsy animal models demonstrate that ANAVEX 2-73 and its active metabolite ANAVEX 19-144 have potent anticonvulsant, anti-amnesic and neuroprotective properties Read more…

Anavex Life Sciences Strengthens Board Of Directors

NewswireToday (newswire) - 01/15/2008 Geneva, Switzerland - Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors Read more…

Chief Diagnostic Radiology at NIH to Speak at 3rd Imaging in Drug Development Conference March 2008

NewswireToday (newswire) - 01/14/2008 Monrovia, CA United States - Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology at NIH will speak at GTCbio?’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego Read more…

Biogen-Idec to Present at GTCbio?’s 6th Cytokines and Inflammation January 28-29, 2008

NewswireToday (newswire) - 01/14/2008 Monrovia, CA United States - Shelia Violette, Director of Discovery Immunology at Biogen-Idec will give a presentation entitled ?“The Alphavbeta6 Integrin: A Mediator of TGF-Beta Activation and Therapeutic Target in Fibrosis and Oncology?” at GTCbio?’s 6th Cytokines Read more…

Schering Plough to Present at GTCbio?’s 6th Cytokines and Inflammation January 28-29, 2008

NewswireToday (newswire) - 01/14/2008 Monrovia, CA United States - Jianhua Chao, Principal Scientist of Discovery Chemical Research at Schering-Plough will give a presentation entitled ?“Potent, Orally Active CXCR2-CXCR1 Antagonists as Anti-inflammatory Therapy?” at GTCbio?’s 6th Cytokines and Inflammation Read more…

FDA strengthens safety info for erythropoiesis-stimulating agents

Physicians and patients should carefully weigh the risks of ESAs against transfusion risks. Read more…

AnaSpec Introduces New FRET Technology Brochure

NewswireToday (newswire) - 01/10/2008 San Jose, CA United States - AnaSpec has developed a broad portfolio of products based on fluorescence energy transfer (FRET) technology, most notably the SensoLyte?™ line of high-performance assay kits Read more…

Multi-Year Contract Extension with Nycomed for Genedata Screener

NewswireToday (newswire) - 01/10/2008 Basel, Switzerland - Genedata, a leading provider of in silico solutions for drug discovery, today announced a multi-year contract extension for the Genedata Screener?® lead discovery product suite with Nycomed, a global manufacturer of innovative pharmaceuticals Read more…

Covance and Care Partner on Rwanda Early Childhood Development Initiative

NewswireToday (newswire) - 01/08/2008 Princeton, NJ United States - Covance Inc. (NYSE: CVD) and CARE announced that they are partnering to support the Covance-CARE Early Childhood Development (ECD) Initiative for Orphans and Vulnerable Children in Rwanda Read more…

Covance Announces Plans to Build New Drug Development Facility in Prince William County Virginia

NewswireToday (newswire) - 01/08/2008 Princeton, NJ United States - Covance Inc. (NYSE: CVD) announced today the purchase of a partially constructed manufacturing facility located on a 47-acre property in Prince William County?’s Technology Park from Eli Lilly Read more…
Online pharmacy Drugshop247 - is the online drugstore where we sell drugs controlling their quality and you buy prescription drugs enjoying our excellent service!